ROYAL BANK OF CANADA - BIOLINERX LTD ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BIOLINERX LTD
ValueSharesWeighting
Q3 2023$4,000
+33.3%
2,0530.0%0.00%
Q2 2023$3,000
+50.0%
2,0530.0%0.00%
Q1 2023$2,000
+100.0%
2,0530.0%0.00%
Q4 2022$1,000
-50.0%
2,0530.0%0.00%
Q3 2022$2,000
-33.3%
2,0530.0%0.00%
Q2 2022$3,0000.0%2,0530.0%0.00%
Q1 2022$3,0002,053
+3010.6%
0.00%
Q4 2021$0660.0%0.00%
Q3 2021$0660.0%0.00%
Q2 2021$0660.0%0.00%
Q1 2021$0660.0%0.00%
Q4 2020$066
-66.8%
0.00%
Q3 2020$01990.0%0.00%
Q2 2020$01990.0%0.00%
Q1 2020$01990.0%0.00%
Q4 2019$01990.0%0.00%
Q3 2019$01990.00%
Other shareholders
BIOLINERX LTD shareholders Q4 2023
NameSharesValueWeighting ↓
BVF INC/IL 1,686,375$2,884,0000.18%
Senvest Management, LLC 451,205$772,0000.05%
Cutter & CO Brokerage, Inc. 17,799$30,0000.01%
Opaleye Management Inc. 16,667$29,0000.01%
Psagot Value Holdings Ltd. 117,000$200,0000.01%
Orbimed Advisors 69,240$118,0000.00%
MORGAN STANLEY 565,114$966,0000.00%
ACADIAN ASSET MANAGEMENT LLC 18,973$32,0000.00%
LPL Financial LLC 19,876$34,0000.00%
Asset Dedication, LLC 366$1,0000.00%
View complete list of BIOLINERX LTD shareholders